B O O K - American College of Rheumatology

ACR Poster Session A
156. Patient Knowledge and Beliefs Concerning Gout and Its
Treatment. Leslie R. Harrold 4 , Kathleen M. Mazor 2 , Daniel
Peterson 3 , Cassandra Firneno 3 and Robert A. Yood 1 , 1 Fallon
Clinic, Worcester, MA, 2 Meyers Primary Care Insitute/UMass
Medical School, 3 Meyers Primary Care Institute, 4 UMass Medical
Schl, Worcester, MA.
157. Progressive Reduction in Tophus Burden with Pegloticase
Therapy in Patients with Chronic Gout Refractory to
Conventional Therapy. Herbert Baraf 1 , Sergio R. Gutierrez-
Urena 4 , Janitzia Vazquez-Mellado 5 , Claudia Rehrig 6 , Faith
Ottery 6 , John S. Sundy 2 and Robert A. Yood 3 , 1 Arthritis &
Rheumatism Association, Wheaton, MD, 2 Duke University
Medical Center, Durham, NC, 3 Fallon Clinic, Worcester, MA,
4
Hospital Civil de Guadelajara, Guadalajara, Mexico, 5 Hospital
General de México, México City, 6 Savient Pharmaceuticals, Inc.
158. Safety and Efficacy of Febuxostat (FEB) Treatment in Subjects
with Gout and Severe Allopurinol (ALLO) Adverse Reactions.
Saima Chohan and Michael A. Becker, University of Chicago,
Chicago, IL.
159. Serum Urate Levels Have an Impact on Renal Function in
Patients with Gout Withdrawing Urate-Lowering Therapy
(ULT). Fernando Perez-Ruiz 1 , Ana M. Herrero-Beites 2 and Miguel
A. Gonzalez-Gay 3 , 1 Hospital de Cruces, Jopelana, Spain, 2 Hospital
de Górliz, 3 Hospital Univesitario Marqués de Valdecilla.
160. The Combination of Tranilast with Allopurinol Results in
Enhanced Urate Lowering. John S. Sundy 4 , Michael M. Kitt 5 ,
Sue G. Griffith 1 , Randall R. Stoltz 2 and Ronald Goldblum 3 ,
1
ClinPharma Resources, San Diego, CA, 2 Covance, Evansville,
IN, 3 CPC Inc, Carlsbad, CA, 4 Duke University Medical Center,
Durham, NC, 5 Nuon Therapeutics, Inc., San Mateo, CA.
161. The Effect of Allopurinol on Renal Function in Patients with
Hyperuricemia: A Case-Control Study. Aneesa Krishnamurthy 1 ,
Deana M. Lazaro 5 , David R. Blumenthal 4 , Donald A. Gerber 2 and
Peter L. Flom 3 , 1 SUNY Downstate Medical Center, Kew Garden
Hills, NY, 2 SUNY Downstate Medical Center, Brooklyn, NY, 3 SUNY
Downstate Medical Center, 4 VA New York Harbor Healthcare
System, Short Hills, NJ, 5 VA New York Harbor Healthcare System
and SUNY Downstate Medical Center, Brooklyn, NY.
162. The Impact of Deficits in Gout Care on Hospitalizations.
Prachaya Nitichaikulvatana 1 , Katherine Upchurch 2 and Leslie
Harrold 2 , 1 University of Massachusetts Medical School,
Worcester, 2 University of Massachusetts Medical School.
163. The Safety and Efficacy of Anakinra in the Treatment of
Acute Gout in Hospitalized Patients. Michael Cho 1 , Pradipta
Ghosh 3 , Gurpreet Hans 4 , Julia J. Rhiannon 2 , Gregory C. Gardner 1
and Peter A. Simkin 1 , 1 University of Washington, Seattle,
WA, 2 University of Washington, Seattle, WA, 3 University of
Washington, Lake Forest Park, WA, 4 University of Washington,
Kirkland, WA.
164. Tranilast Inhibits Urate Transport Mediated by URAT1 and
GLUT9. Asim Mandal 3 , Daniel Emerling 1 , Tito Serafini 1 and David
B. Mount 2 , 1 Nuon Therapeutics, Inc., San Mateo, CA 94403,
2
Renal Division, VA Boston Healthcare System and Brigham &
Women’s Hospital, Harvard Medical School, Boston, MA, 3 Renal
Division, VA Boston Healthcare System and Brigham & Women’s
Hospital, Harvard Medical School, Boston, MA 02115.
165. Urate-Lowering (UL) Efficacy and Safety of Febuxostat (FEB)
and Allopurinol (ALLO) in Women with Gout, an Older Subset
of Gout Subjects with Increased Comorbidity. Saima Chohan 3 ,
Michael A. Becker 3 , Patricia A. MacDonald 1 , Solomon Chefo 2
and Robert Jackson 2 , 1 Takeda Global R&D Inc, Lake Forest, IL,
2
Takeda Global Research & Development Center, Inc, Deerfield,
IL, 3 University of Chicago, Chicago, IL.
166. Use of Pegloticase in Chronic Gout Refractory to Conventional
Therapy Is Associated with Significant Clinical Benefit: Tender
Joint and Swollen Joint Counts and Patient Global Assessment
(Health Assessment Questionnaire). David R. Mandel 3 , Herbert
Baraf 1 , Claudia Rehrig 5 , Zebulun D. Horowitz 6 , Faith D. Ottery 4
and Robert A. Yood 2 , 1 Arthritis & Rheumatism Association,
Wheaton, MD, 2 Fallon Clinic, Worcester, MA, 3 Private
Practive, Mayfield Village, OH, 4 Savient Pharmaceuticals, Inc,
5
Savient Pharmaceuticals, Inc., 6 Savient Pharmaceuticals, Inc.,
Baskingridge, NJ.
Orthopedics, Low Back Pain, and Rehabilitation
167. A Specific Chemokine Expression Pattern Is Associated
with Synovial Inflammation and Symptoms in Patients with
Traumatic Knee Injury Undergoing Arthroscopic Meniscectomy.
Carla R. Scanzello 7 , Brian McKeon 6 , Bryan H. Swaim 6 , Edward
DiCarlo 5 , Eva Umoh 4 , Veero Kanda 8 , Anjali Nair 8 , David M. Lee 2 ,
John C. Richmond 6 , Jeffrey N. Katz 1 , Mary K. Crow 3 and Steven
R. Goldring 3 , 1 Brigham & Womens Hosp, Boston, MA, 2 Brigham
and Womens Hospital, Boston, MA, 3 Hospital for Special
Surgery, New York, NY, 4 Hospital for Special Surgery, New York
NY, 5 Hosptial for Special Surgery, New York NY, 6 New England
Baptist Hospital, Boston MA, 7 Rush University Medical Center,
Chicago, IL, 8 Rush University Medical Center, Chicago IL.
168. A Systematic Review and Meta-Analysis of the Impact of
Total Shoulder Arthroplasty on Health-Related Quality of
Life. Michael J. Carter 1 , Ted R. Mikuls 1 , Smita Nayak 2 , Edward V.
Fehringer 1 and Kaleb D. Michaud 1 , 1 Univ of Nebraska Med Ctr,
Omaha, NE, 2 University of Pittsburgh, Pittsburgh, PA.
169. Cane Use in Hip Osteoarthritis. Karen L. Perell-Gerson 1 ,
Constance Heiney 4 , Nancy D. Harada 4 , Jennifer M. Yentes 2 ,
Sulabha Masih 4 and Meika A. Fang 3 , 1 Georgia Gwinnett College,
Lawrenceville, GA, 2 University of Nebraska at Omaha, 3 VA
Greater Los Angeles Healthcare System, Los Angeles, CA, 4 VA
Greater Los Angeles Healthcare System, Los Angeles, CA.
170. Comorbid Subjective Health Complaints in Patients with
Sciatica, a Prospective Study Including Comparison with
the General Population. Lars Grøvle 2 , Anne J. Haugen 2 ,
Camilla Ihlebaek 5 , Anne Keller 1 , Bård Natvig 4 , Jens I. Brox 6
and Margreth Grotle 3 , 1 Department of Physical Medicine and
Rehabilitation, Oslo University Hospital, Ullevaal, 2 Department
of Rheumatology, Østfold Hospital Trust, Fredrikstad, Norway,
3
FORMI (Communication Unit for Musculoskeletal Disorders),
Oslo University Hospital, Ullevaal, 4 National Resource Centre
for Rehabilitation in Rheumatology, Diakonhjemmet Hospital
& Department of General Practice and Community Medicine,
ASAM, University of Oslo, 5 Research Group of Nature, Health
and Quality of Life, Norwegian University of Life Sciences,
Aas, 6 Section for Back Surgery and Physical Medicine and
Rehabilitation, Orthopaedic Department, Oslo University
Hospital, Rikshospitalet.
158
2010 Program Book